1st injectable antibiotic bone graft substitute gets FDA authorization

Bonesupport’s Cerament G, an injectable combination antibiotic bone graft substitute, earned FDA market authorization.

Advertisement

Cerament G is the first injectable of its kind and can be delivered in a single procedure to support bone remodeling and protect bone healing, according to a May 19 news release. It is designed to prevent bone infection that can arise from fractures, orthopedic implants and foot ulcers. 

“This is a significant recognition for the power and promise of our technology, as we are the first-to-market in the U.S. with this breakthrough combination device,” Bonesupport CEO Emil Billbaeck said in the release. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.